These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1352 related articles for article (PubMed ID: 10229661)

  • 1. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation.
    Stack MS; Gately S; Bafetti LM; Enghild JJ; Soff GA
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):77-84. PubMed ID: 10229661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiostatin binds ATP synthase on the surface of human endothelial cells.
    Moser TL; Stack MS; Asplin I; Enghild JJ; Højrup P; Everitt L; Hubchak S; Schnaper HW; Pizzo SV
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2811-6. PubMed ID: 10077593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin.
    Tarui T; Majumdar M; Miles LA; Ruf W; Takada Y
    J Biol Chem; 2002 Sep; 277(37):33564-70. PubMed ID: 12087108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage formation of angiostatin during inflammation. A byproduct of the activation of plasminogen.
    Falcone DJ; Khan KM; Layne T; Fernandes L
    J Biol Chem; 1998 Nov; 273(47):31480-5. PubMed ID: 9813061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen.
    Brauer R; Beck IM; Roderfeld M; Roeb E; Sedlacek R
    BMC Biochem; 2011 Jul; 12():38. PubMed ID: 21787393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiostatin binds to tyrosine kinase substrate annexin II through the lysine-binding domain in endothelial cells.
    Tuszynski GP; Sharma MR; Rothman VL; Sharma MC
    Microvasc Res; 2002 Nov; 64(3):448-62. PubMed ID: 12453439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis.
    Ji WR; Castellino FJ; Chang Y; Deford ME; Gray H; Villarreal X; Kondri ME; Marti DN; Llinás M; Schaller J; Kramer RA; Trail PA
    FASEB J; 1998 Dec; 12(15):1731-8. PubMed ID: 9837863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action.
    Sharma MR; Rothman V; Tuszynski GP; Sharma MC
    Exp Mol Pathol; 2006 Oct; 81(2):136-45. PubMed ID: 16643891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble tissue actor interferes with angiostatin-mediated inhibition of endothelial cell proliferation by lysine-specific interaction with plasminogen kringle domains.
    Albrecht S; Magdolen V; Herzog U; Miles L; Kirschenhofer A; Baretton G; Luther T
    Thromb Haemost; 2002 Dec; 88(6):1054-9. PubMed ID: 12529759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis.
    Ji WR; Barrientos LG; Llinás M; Gray H; Villarreal X; DeFord ME; Castellino FJ; Kramer RA; Trail PA
    Biochem Biophys Res Commun; 1998 Jun; 247(2):414-9. PubMed ID: 9642142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of angiostatins on activity of the plasminogen/plasminogen activator system.
    Aisina RB; Mukhametova LI; Gulin DA; Levashov MY; Prisyazhnaya NV; Gershkovich KB; Varfolomeyev SD
    Biochemistry (Mosc); 2009 Oct; 74(10):1104-13. PubMed ID: 19916923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different inhibitors of plasmin differentially affect angiostatin production and angiogenesis.
    Hatziapostolou M; Katsoris P; Papadimitriou E
    Eur J Pharmacol; 2003 Jan; 460(1):1-8. PubMed ID: 12535853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiostatin(4.5)-mediated apoptosis of vascular endothelial cells.
    Hanford HA; Wong CA; Kassan H; Cundiff DL; Chandel N; Underwood S; Mitchell CA; Soff GA
    Cancer Res; 2003 Jul; 63(14):4275-80. PubMed ID: 12874037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis.
    Cao R; Wu HL; Veitonmäki N; Linden P; Farnebo J; Shi GY; Cao Y
    Proc Natl Acad Sci U S A; 1999 May; 96(10):5728-33. PubMed ID: 10318952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth.
    O'Reilly MS
    EXS; 1997; 79():273-94. PubMed ID: 9002223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited plasmin proteolysis of vitronectin. Characterization of the adhesion protein as morpho-regulatory and angiostatin-binding factor.
    Kost C; Benner K; Stockmann A; Linder D; Preissner KT
    Eur J Biochem; 1996 Mar; 236(2):682-8. PubMed ID: 8612645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation.
    Troyanovsky B; Levchenko T; Månsson G; Matvijenko O; Holmgren L
    J Cell Biol; 2001 Mar; 152(6):1247-54. PubMed ID: 11257124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells.
    Cao Y; Ji RW; Davidson D; Schaller J; Marti D; Söhndel S; McCance SG; O'Reilly MS; Llinás M; Folkman J
    J Biol Chem; 1996 Nov; 271(46):29461-7. PubMed ID: 8910613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonlysine-analog plasminogen modulators promote autoproteolytic generation of plasmin(ogen) fragments with angiostatin-like activity.
    Ohyama S; Harada T; Chikanishi T; Miura Y; Hasumi K
    Eur J Biochem; 2004 Feb; 271(4):809-20. PubMed ID: 14764098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiostatin diminishes activation of the mitogen-activated protein kinases ERK-1 and ERK-2 in human dermal microvascular endothelial cells.
    Redlitz A; Daum G; Sage EH
    J Vasc Res; 1999; 36(1):28-34. PubMed ID: 10050071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.